Nara Organics Infant Formula Recall: Current FDA Findings
Updated: Oct 6
Reviewed and updated October 6, 2026.
FDA and CDC investigated four confirmed cases of infant botulism among infants who consumed Nara Organics Whole Milk Organic Powdered Infant Formula. All four infants were hospitalized; no deaths were reported. Illnesses occurred in California, Pennsylvania, and Washington, with the last onset on May 31, 2026.
FDA now says the outbreak is over and the outbreak investigation has ended. That does not cancel the recall. All lots of the formula were recalled, products have “Best By” dates ending in 2027, and FDA tells families to check their homes and discard any remaining cans.
Which formula was recalled
Nara Organics recalled all lots of its Whole Milk Organic Powdered Infant Formula then on the market:
700-gram cans, UPC 860013251901; and
400-gram cans, UPC 860013251918.
The FDA recall page lists the 16 lot codes and shows where the code appears on the can. The product was distributed nationwide through Target stores, Target.com, and Nara.com from July 2025 through June 2026.
Because every marketed lot was recalled, a family should not use a remaining can while trying to narrow it to one of the illness-associated lots. FDA says recalled product should no longer be for sale.
What the final outbreak update established
FDA’s August 27 outbreak update reports:
four confirmed infant-botulism illnesses, all hospitalized, with no deaths;
all four infants consumed Nara Organics formula;
a clinical sample from one infant genetically matched a sample from the 2025 ByHeart outbreak, a powdered-formula-base sample from that investigation, and four unopened cans of ByHeart formula; and
illness-linked Nara lots used milk supplied by Organic West Milk and spray-dried by Dairy Farmers of America, the same suppliers identified in the earlier ByHeart investigation.
FDA concluded that the genetic results and supply-chain commonalities indicate a common source of contamination between the outbreaks. But the agency also said the evidence was insufficient to determine whether contamination occurred before drying or during the drying process. Its root-cause work continues through post-incident activities.
That is the correct line between finding and inference: FDA identified a common source; it has not publicly fixed the precise contamination point or assigned civil fault. The related ByHeart infant-formula article should be read with that distinction in mind.
What families should do now
Do not feed a recalled can to an infant. Follow the FDA instruction to discard it.
Wash bottles, formula dispensers, counters, and other items or surfaces that may have touched the formula with hot soapy water or in a dishwasher, as FDA directs.
Photograph the can, lot code, UPC, “Best By” date, receipt, and order history before disposal. Preserve refund confirmations and any communication with the seller or manufacturer.
Watch for constipation, poor feeding, loss of head control, difficulty swallowing, decreased facial expression, weak or altered cry, drooping eyelids, low muscle tone, or breathing difficulty.
Treat possible botulism as an emergency. CDC says a child with signs or symptoms should be seen immediately by a doctor or at an emergency department; do not wait.
FDA explains that symptoms can take several weeks to develop after formula ingestion. A parent should give the clinician the product, lot, feeding dates, symptom timeline, and recall information. Do not delay care to assemble records.
Legal causation remains person-specific
The FDA findings are substantial public-health evidence, but they do not prove that every recalled can contained spores or that every symptom after feeding was botulism. An individual claim may turn on the product record, exposure dates, clinical diagnosis, laboratory information, hospitalization, damages, and the responsible entities in the supply chain.
If an infant consumed recalled Nara formula and received a botulism diagnosis or treatment, preserve the records and request an initial case evaluation. Medical care comes first.
Primary sources
This article provides general information, not legal or medical advice. Botulism is a medical emergency; seek immediate care for a child with possible symptoms. Recall information can change, so use the linked FDA page for current instructions. Reading this article or contacting the firm does not create an attorney-client relationship. Representation begins only after the firm accepts the matter in writing. Do not send medical records, confidential information, or time-critical material through a website form.
